Genetic Variation in the HR Region of the env Gene of HIV: A Perspective for Resistance to HIV Fusion Inhibitors
Explore this paper's citation graph
Summary
It is concluded from this study that viruses in this population may show resistance to C30 and T20 whereas the other fusion inhibitors may be effectively used for the authors' population.
- Type
- article
- Published
- 2011-01-01
- Cited by
- 20
- References
- 27
- OpenAlex
- https://openalex.org/W1964386770
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:44371106
Keywords
Enfuvirtide, Virology, Population, Biology, Cell fusion
References
- Analysis of Genetic Variability within the Immunodominant Epitopes of Envelope gp41 from Human Immunodeficiency Virus Type 1 (HIV-1) Group M and Its Impact on HIV-1 Antibody Detection
- Structure of Proteins
- Phenotypic or genotypic resistance testing for choosing antiretroviral therapy after treatment failure: a randomized trial
- Peptide, Peptidomimetic and Small‐molecule Drug Discovery Targeting HIV‐1 Host‐cell Attachment and Entry through gp120, gp41, CCR5 and CXCR4 †
- Clinical utility of HIV-1 genotyping and expert advice: the Havana trial
- Endoproteolytic cleavage of gp160 is required for the activation of human immunodeficiency virus.
- HIV fusion inhibitors
- Principles of protein-protein interactions.
- V3 loop region of the HIV-1 gp120 envelope protein is essential for virus infectivity.
- HIV Drug Resistance
- Atomic structure of the ectodomain from HIV-1 gp41
- Protein Design of an HIV-1 Entry Inhibitor
- Usefulness of monitoring HIV drug resistance and adherence in individuals failing highly active antiretroviral therapy: a randomized study (ARGENTA)
- Elite Suppressor–Derived HIV-1 Envelope Glycoproteins Exhibit Reduced Entry Efficiency and Kinetics
- A role for surface hydrophobicity in protein‐protein recognition
- The Six-Helix Bundle of Human Immunodeficiency Virus Env Controls Pore Formation and Enlargement and Is Initiated at Residues Proximal to the Hairpin Turn
- Characterization of determinants of genotypic and phenotypic resistance to enfuvirtide in baseline and on-treatment HIV-1 isolates
- A randomized study of antiretroviral management based on plasma genotypic antiretroviral resistance testing in patients failing therapy
- Human immunodeficiency virus infection of cells arrested in the cell cycle.
- STRUCTURE OF PROTEINS.
Cited by
- Review: probiotics and their beneficial effects against various diseases.
- Spasmolytic, bronchodilator and vasodilator activities of aqueousmethanolic extract of Ocimum basilicum.
- Revitalizing the HIV response in Pakistan : a systematic review and policy recommendations - synthesis report
- Novel drugs from marine microorganisms
- Tuberculosis – burning issues: Multidrug resistance and HIV-coinfection
- Revitalizing the HIV response in Pakistan: a systematic review and policy implications.
- A novel view of modelling interactions between synthetic and biological polymers via docking
- Cytotoxic Effect of Ethanol Extract of Convolvulus arvensis L (Convolvulaceae) on Lymphoblastic Leukemia Jurkat Cells
- Review: Ajwa date (Phoenix dactylifera)- an emerging plant in pharmacological research.
- Vascular endothelial growth factor (VEGF) in cancer
- Phage therapy: A modern tool to control bacterial infections
- Dengue fever: natural management.
- Analgesic, anti-inflammatory and anti-pyretic activities of aqueous ethanolic extract of Tamarix aphylla L. (Saltcedar) in mice.
- Review: HIV-Plasmodium Co-infection: Malaria in AIDS patients.
- Skin cancer: Etiology and management.
- AIDS-related malignancies
- Revitalizing the HIV Response in Pakistan
- Hepatitis in AIDS patients
- ANTIOXIDANT AND CYTOTOXIC POTENTIAL OF CHRYSANTHEMUM MORIFOLIUM AND CONVOLVULUS ARVENSIS EXTRACTS: A PROMISING SOURCE OF BIOACTIVE COMPOUNDS FOR MEDICINAL APPLICATIONS
- A REVIEW ON APPLICATIONS OF PROBIOTICS IN HUMAN HEALTH AND DISEASE
Related papers
- Interruption of enfuvirtide in HIV-1 infected adults with incomplete viral suppression on an enfuvirtide-based regimen.
- Enfuvirtide: A Novel Agent for the Treatment of HIV-1 Infection
- Enfuvirtide
- Enfuvirtide: first fusion inhibitor for treatment of HIV infection.
- Enfuvirtide: A Review of its Use in the Management of HIV Infection
- A cohort study of enfuvirtide immunological and virological efficacy in clinical practice
- Trends in drug development for the treatment of AIDS compounds interfering with the initial stages of the HIV replicative cycle